Table 6. SCNP nodes likely contribute unique data for the prediction of DFS in FLT3 WT AML.

Model	Node1	Node2	P Model*	P Node1†	P Node2†
#1	AraC+Daunorubicin→cPARP | Uu	FLT3L→p-S6 | log2 fold	0.046	0.033	0.034
#2	Etoposide→cPARP | Uu	FLT3L→p-S6 | log2 fold	0.038	0.037	0.022

log h(t) = β₀+β₁*Node1+β₂*Node2.

Sample size n = 29 for each row.

^*Wald test used.

^†t-test(H0:Slope = 0). Significant p-value suggests influence of model component on hazard ratio.